Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres

被引:121
作者
Araujo, J. [2 ]
Vega, E. [2 ]
Lopes, C. [1 ,3 ]
Egea, M. A. [2 ]
Garcia, M. L. [2 ]
Souto, E. B. [1 ,3 ]
机构
[1] Fernando Pessoa Univ, Fac Hlth Sci, Dept Pharmaceut Technol, P-4200150 Oporto, Portugal
[2] Univ Barcelona, Fac Pharm, Inst Nanosci & Nanotechnol, Dept Phys Chem, E-08028 Barcelona, Spain
[3] Univ Tras Os Montes & Alto Douro, Ctr Genet & Biotechnol, Inst Biotechnol & Bioengn, P-5000801 Vila Real, Portugal
关键词
Flurbiprofen; Poly(lactic-co-glycolic) acid (PLGA); Inherent viscosity; Nanospheres; Ocular administration; HET-CAM; DRUG-DELIVERY; NANOPARTICLES; RELEASE; MICROPARTICLES; FORMULATION; NANOPRECIPITATION; EMULSION; BEHAVIOR; CARRIERS; DEVICES;
D O I
10.1016/j.colsurfb.2009.03.028
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Poly(lactide-co-glycolide) acid (PLGA) nanospheres incorporating flurbiprofen (FB) were produced by the solvent displacement technique, for ocular applications aiming to avoid/minimize inflammation induced by surgical trauma. In this work. a PLGA of low viscosity has been tested and the results obtained were compared with those previously reported by Vega et al. The physicochemical properties of the developed formulations were evaluated by measuring particle size, zeta potential and FB entrapment efficiency, showing no significant differences. Release studies demonstrated that the formulation produced with PLGA of higher viscosity revealed a slower drug release rate. Stability analysis, for a period of 75 days, was performed using three complementary methods: (i) turbidity experiments using a Turbiscan optical analyzer, (ii) particle size measurements, and (iii) zeta potential analysis. The results revealed long-term physicochemical stability suitability for ophthalmic use, being independent from the polymer viscosity. The ocular tolerance was assessed by an alternative in vitro method to animal experimentation, the HET-CAM. For all developed formulations no ocular irritancy has been detected. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 44 条
[31]   Preparation and characterization of triclosan nanoparticles for periodontal treatment [J].
Piñón-Segundo, E ;
Ganem-Quintanar, A ;
Alonso-Pérez, V ;
Quintanar-Guerrero, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 294 (1-2) :217-232
[32]   Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery [J].
Reis, Catarina Pinto ;
Ribeiro, Antonio J. ;
Veiga, Francisco ;
Neufeld, Ronald J. ;
Damge, Christiane .
DRUG DELIVERY, 2008, 15 (02) :127-139
[33]   Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles [J].
Reis, Catarina Pinto ;
Neufeld, Ronald J. ;
Ribeiro, Antonio J. ;
Veiga, Francisco .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2006, 2 (01) :8-21
[34]   EFFECT OF PARTICLE-SIZE ON OPHTHALMIC BIOAVAILABILITY OF DEXAMETHASONE SUSPENSIONS IN RABBITS [J].
SCHOENWALD, RD ;
STEWART, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (04) :391-394
[35]   Safety Assessment of Poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, Poloxamer 105 Benzoate, and Poloxamer 182 Dibenzoate as Used in Cosmetics [J].
Singh-Joy, Subhashni D. ;
McLain, Valerie C. .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2008, 27 :93-128
[36]  
Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/s0168-3659(00)00339-4
[37]   Nanotechnology-based drug delivery systems [J].
Suri S.S. ;
Fenniri H. ;
Singh B. .
Journal of Occupational Medicine and Toxicology, 2 (1)
[38]   Intracellular delivery of nanoparticles of an antiasthmatic drug [J].
Surti, Naazneen ;
Naik, Sachin ;
Bagchi, Tamishraha ;
Dwarkanath, B. S. ;
Misra, Ambikanandan .
AAPS PHARMSCITECH, 2008, 9 (01) :217-223
[39]  
Tavaszi J, 2007, Commun Agric Appl Biol Sci, V72, P137
[40]   Diclofenac sodium incorporated PLGA (50:50) microspheres:: formulation considerations and in vitro/in vivo evaluation [J].
Tunçay, M ;
Çalis, S ;
Kas, HS ;
Ercan, MT ;
Peksoy, I ;
Hincal, AA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :179-188